The drug efflux pump MRP2: Regulation of expression in physiopathological situations and by endogenous and exogenous compounds

Cell Biology and Toxicology

Volumn 18, Issue 4, 2002, Pages 221-233

  Payen, L ^a   Sparfel, L ^a   Courtois, A ^a   Vernhet, L ^a   Guillouzo, A ^a   Fardel, Olivier ^a  

^a INSERM   (France)

Author keywords

Hepatocytes; Hormone; Multidrug resistance associated protein 2; Pregnane X receptor; Xenobiotic

Indexed keywords

ABC TRANSPORTER; ANION; ANTINEOPLASTIC AGENT; BILIRUBIN; CARCINOGEN; CISPLATIN; DRUG METABOLIZING ENZYME; ENDOGENOUS COMPOUND; GLUCOCORTICOID; HORMONE; HORMONE RECEPTOR; MULTIDRUG RESISTANCE PROTEIN 2; N (2 FLUORENYL)ACETAMIDE; OLTIPRAZ; PHENOBARBITAL; PREGNANE X RECEPTOR; PROTEIN; RIFAMPICIN; RITONAVIR; SULFORAPHANE; TOXIC SUBSTANCE; CARRIER PROTEIN; CELL RECEPTOR; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; STEROID RECEPTOR; XENOBIOTIC AGENT;

ANIMAL CELL; BILE SECRETION; CANCER TISSUE; CONTROLLED STUDY; DRUG ELIMINATION; GENE EXPRESSION REGULATION; INTESTINE SECRETION; INTRAHEPATIC CHOLESTASIS; KIDNEY TUBULE EXCRETION; LIVER CELL; LIVER PARENCHYMA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REVIEW; ANIMAL; BIOSYNTHESIS; CELL MEMBRANE; CHOLESTASIS; CYTOLOGY; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LIVER; METABOLISM;

ANIMALIA;

ANIMALS; CARCINOGENS; CELL MEMBRANE; CHOLESTASIS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HORMONES; HUMANS; LIVER; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; RNA, MESSENGER; TRANSCRIPTION, GENETIC; XENOBIOTICS;

EID: 0036021113     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016020626941     Document Type: Review

References (92)

1. Cloning of the beta cell high-affinity sulfonylurea receptor: A regulator of insulin secretion
2. Characterization of the amino-terminal regions in the human multidrug resistance protein (MRPI)
3. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver
4. Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells
5. The multidrug resistance protein family
6. A family of drug transporters: The multidrug resistance-associated proteins
7. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats
8. MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells
9. Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin
10. Organ distribution of multidrug resistance proteins 1, 2, and 3 (mrp1, 2, and 3) mRNA and hepatic induction of mrp3 by constitutive androstane receptor activators in rats
11. Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone
12. Differential regulation of canalicular multispecific organic anion transporter (cMOAT) expression by the chemopreventive agent oltipraz in primary rat hepatocytes and in rat liver
13. Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbitaltreated hepatocytes
14. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells
15. Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter
16. Dexamethasone modulation of multidrug transporters in normal tissues
17. Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation
18. Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine
19. Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats
20. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver
21. +-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation
22. Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR
23. Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export
24. Regulation of biliary drug efflux pump expression by hormones and xenobiotics
25. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver
26. The effect of rifampin treatment on intestinal expression of human MRP transporters
27. +/bile acid cotransporter in extrahepatic cholestasis
28. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents
29. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas
30. Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily
31. Mrp2 is essential for estradiol-1713 (β-D)-glucuronide)-induced cholestasis in rats
32. Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins
33. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR
34. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis
35. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic
36. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome
37. Regulation of multidrug resistance-associated protein 2 (MRP2; ABCC2) by the nuclear receptors PXR, FXR, and CAR
38. Sequence analysis and functional characterization of the 5′-flanking region of the rat multidrug resistance protein 2 (mrp2) gene
39. Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen
40. Hepatic secretion of conjugated drugs and endogenous substances
41. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRPI and its apical isoform MRP2
42. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)
43. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway
44. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells
45. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance
46. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRPI), in human cancer cell lines
47. MRP3, an organic anion transporter able to transport anti-cancer drugs
48. Osmodependent dynamic localization of the multidrug resistance protein 2 in the rat hepatocyte canalicular membrane
49. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone
50. Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure
51. High multidrug resistance protein (MRP) activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival
52. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat
53. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter
54. Toxicological relevance of the multidrug resistance protein 1, MRPI (ABCC1) and related transporters
55. Differential sensitivities of the MRP gene family and gamma-glutamylcysteine synthetase to prooxidants in human colorectal carcinoma cell lines with different p53 status
56. Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic
57. Endothelin B receptor-mediated regulation of ATP-driven drug secretion in renal proximal tubule
58. Bile salt transporters
59. Expression of multidrug resistance-associated protein 2 in small intestine from pregnant and postpartum rats
60. Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression
61. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells
62. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma
63. Characterization of inducible nature of MRP3 in rat liver
64. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
65. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene
66. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome
67. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione
68. The multidrug resistance-associated protein (MRP) is over-expressed and functional in rat hepatoma cells
69. Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes
70. Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane
71. The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells
72. Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRP1 transporting protein
73. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis
74. Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia
75. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules
76. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
77. The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma
78. Characterization of the 5′-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison with the multidrug resistance protein 3 (MRP3) gene
79. Expression of members of the multidrug resistance protein family in human term placenta
80. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation
81. Nephrotoxicants induce endothelin release and signaling in renal proximal tubules: Effect on drug efflux
82. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis
83. Molecular pharmacology of renal organic anion transporters
84. + peripheral blood cells
85. Arsenic induces expression of the multidrug resistance-associated protein 2 (MRP2) gene in primary rat and human hepatocytes
86. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver
87. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats
88. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
89. Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver
90. Expression of multidrug resistance protein-related genes in lung cancer: Correlation with drug response
91. Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin
92. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases